Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

22.11.16	Survey Reveals Most People Don't Know Heart Disease Is the No. 1 Killer of People with Type 2 Diabetes (PR Newswire)
14.11.16	Lilly Says New Analyses Of Phase 3 Trials Show Improvements In RA Symptom (RTTNews)
25.10.16	Lilly Q3 Results Miss Estimates; Cuts FY16 EPS View, Backs Adj. EPS Forecast (RTTNews)
25.10.16	Eli Lilly And Co. Q3 Profit Declines 2% (RTTNews)
20.10.16	CERU Gains Big On Nanoparticle Deal, LLY Gets FDA Nod, BABY Makes Big Strides (RTTNews)
19.10.16	Eli Lilly Announces FDA Approval For LARTRUVO - Quick Facts (RTTNews)
05.10.16	Eli Lilly Unit To Buy BIVI's U.S. Feline, Canine And Rabies Vaccines Portfo (RTTNews)
05.10.16	Elanco Animal Health Enters Agreement to Acquire Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio (EN, Eli Lilly)
16.09.16	Eli Lilly: CHMP Issues Positive Opinion On Conditional Approval For Olaratumab (RTTNews)
08.09.16	Eli Lilly Posting Strong Gain After JPMorgan Chase Upgrade (RTTNews)
22.08.16	Eli Lilly, AstraZeneca Get Fast Track Designation For AZD3293 (RTTNews)
10.08.16	Lilly Updates On MONARCH 2 Phase 3 Trial Of Abemaciclib (RTTNews)
27.07.16	Eli Lilly CEO John Lechleiter To Retire; David Ricks To Succeed - Quick Facts (RTTNews)
26.07.16	Eli Lilly And Co. Reports 5% Drop In Q2 Bottom Line (RTTNews)
13.07.16	Lilly, Boehringer Ingelheim Collaborate On Metastatic Breast Cancer Trial (RTTNews)
29.06.16	ANTH Dims On BRIGHT-SC Data, CYAD Fails To Chart, LLY Gets FDA Panel Nod (RTTNews)
29.06.16	Lilly : FDA Panel Recommends Approval Of Jardiance For Cardiovascular Indication (RTTNews)
23.06.16	Incyte: Ruxolitinib Receives Breakthrough Therapy Designation - Quick Facts (RTTNews)
15.06.16	German Court Grants Lilly Appeal In Alimta Vitamin Regimen Patent Lawsuit (RTTNews)
09.06.16	Lilly : Baricitinib Reduces Joint Damage Progression In Rheumatoid Arthritis (RTTNews)
01.06.16	BMRN Pulls The Plug On DMD Drug, LXRX To Face FDA In Nov, TEVA Snubbed (RTTNews)
31.05.16	Lilly : FDA Oks Once-daily Jentadueto XR Tablets For Adults With Type 2 Diabetes (RTTNews)
05.05.16	CNAT Rises On Trial Data, WMGI Boosts Forecast, RMTI Pays Price For Launch Delay (RTTNews)
04.05.16	Eli Lilly: FDA Grants Priority Review For Olaratumab - Quick Facts (RTTNews)
26.04.16	Eli Lilly Increases 2016 Financial Guidance - Quick Facts (RTTNews)
26.04.16	Eli Lilly And Co. Q1 Profit Falls 4% (RTTNews)
26.04.16	AZN Breathes Easy, EXEL Scores FDA Nod, SRPT Disappointed, PETX On The Rise (RTTNews)
19.04.16	HRTX Abuzz, ILMN Disappoints, STEM Grows, LLY Abandons TTHI's Diabetes Drug (RTTNews)
18.04.16	Transition: Lilly Not To Advance Diabetes Drug Candidate TT401 To Phase 3 (RTTNews)
11.04.16	BSX Recalls Fetch 2 Catheter, CLVS Awaits FDA Panel Vote, LLY, AZN On Watch (RTTNews)
08.04.16	Astrazeneca, Lilly To Continue Pivotal Trial For Early Alzheimer's Disease (RTTNews)
06.04.16	Incyte Acquires Rights To Ruxolitinib From Eli Lilly - Quick Facts (RTTNews)
31.03.16	Eli Lilly's Baricitinib Study Published In New England Journal Of Medicine (RTTNews)
23.03.16	LLY Gets FDA Nod, MRK Scores Legal Win, AFFX Pursued By Origin Technologies (RTTNews)
23.03.16	Lilly's Taltz Gets FDA Approval To Treat Moderate-to-Severe Plaque Psoriasis (RTTNews)
16.03.16	Abbott's Stent Gets Panel Nod, OPXA Awaits Data In Q4, It's A Yes For SPPI (RTTNews)
15.03.16	Lilly Changes Primary Endpoint Of EXPEDITION3 Study (RTTNews)
07.03.16	TNXP Awaits Data In Q2, LLY Uncovers Ixekizumab's Potential, High Five For MNOV (RTTNews)
01.03.16	Lilly To Present Phase 3 Data For Ixekizumab In Psoriasis & Psoriatic Arthritis (RTTNews)
12.02.16	Eli Lilly: Court Rules Against Company In Alimta Vitamin Regimen Patent Lawsuit (RTTNews)
28.01.16	Eli Lilly Reiterates 2016 Adj. Earnings, Revenue Outlook - Quick Facts (RTTNews)
28.01.16	Eli Lilly And Co. Reveals 6% Decline In Q4 Profit (RTTNews)
28.01.16	NEOS Gets Much Needed Attention, AKRX Breathes Easy, INCY Halts Study (RTTNews)
25.01.16	Lilly Says FDA Accepts Filing Of Cardiovascular Outcomes Data For Jardiance (RTTNews)
21.01.16	FDA Oks Lilly's Humulin R U-500 KwikPen, Insulin Human Injection (RTTNews)
19.01.16	Lilly Submits NDA To FDA For Oral Once-Daily Baricitinib; Backs FY16 EPS View (RTTNews)
05.01.16	Eli Lilly Cuts 2015 EPS Outlook; Sees 2016 Below View - Quick Facts (RTTNews)
01.01.16	Novartis India Sells Animal Health Business To Elanco (RTTNews)
21.12.15	Halozyme Enters Into Global Collaboration And Licensing Deal With Lilly (RTTNews)
17.12.15	Eli Lilly : FDA Okays Basaglar, Long-Acting Insulin Treatment (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus
20.12.24		Handel in Zürich: SMI verbucht Verluste
20.12.24		Zurückhaltung in Europa: Euro STOXX 50 präsentiert sich schwächer

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus